Guido Frank
University of California, San Diego
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Guido Frank as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:48 UTC. Open this list on ClinicalTrials.gov
- N/ANCT06000774 · Therapeutic Ketogenic Diet in Anorexia NervosaUniversity of California, San Diego · recruiting · Anorexia Nervosa in Remission, Bulimia Nervosa, Anorexia Nervosa · principal investigator
- N/ANCT05834816 · Stress and Neurofeedback in Anorexia NervosaUniversity of California, San Diego · terminated · Anorexia Nervosa, Atypical Anorexia Nervosa · principal investigator
- N/ANCT05507008 · Ketone Supplementation in Eating DisordersUniversity of California, San Diego · completed · Anorexia Nervosa, Bulimia Nervosa, Atypical Anorexia Nervosa · principal investigator
- N/ANCT05368844 · Transcranial Magnetic Stimulation (TMS) in the Treatment of Anorexia NervosaUniversity of California, San Diego · terminated · Anorexia Nervosa · principal investigator
- N/ANCT04583774 · Developing an EEG Paradigm to Study Prediction Error in Anorexia NervosaUniversity of California, San Diego · active not recruiting · Anorexia Nervosa · principal investigator
- Early Ph1NCT04128683 · Dopamine Receptor Contributions to Prediction Error and Reversal Learning in Anorexia NervosaUniversity of California, San Diego · completed · Anorexia Nervosa · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:48 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 4 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Ketogenic Diet in Weight Recovered Anorexia Nervosa to Target Metabolism and Normalize Persistent Eating Disorder PsychopathologyR33MH134909 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · fiscal years 2026 · $879,294 awarded in 2026Same name and institution; not confirmed by an ID
- Ketogenic Diet in Weight Recovered Anorexia Nervosa to Target Metabolism and Normalize Persistent Eating Disorder PsychopathologyR61MH134909 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · fiscal years 2024 to 2025 · $868,303 awarded in 2025Same name and institution; not confirmed by an ID
- Neural Effects of Negative Affect on Food Choices and Reward Processing In Individuals with Binge Eating EpisodesR01MH112681 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · fiscal years 2018 to 2022 · $719,741 awarded in 2022Same name and institution; not confirmed by an ID
- Developing a computational electroencephalogram (EEG) paradigm to study prediction error in anorexia nervosaR21MH120355 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · fiscal years 2020 to 2021 · $236,813 awarded in 2021Same name and institution; not confirmed by an ID
- Toward understanding dopamine receptor contributions to prediction error and reversal learning in anorexia nervosaR21MH120475 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · fiscal years 2019 to 2020 · $196,875 awarded in 2020Grant number is on one of their registry trials
- BRAIN NEURONAL ACTIVITY IN RESPONSE TO SUCROSE VS SUCRALOSE TASTE STIMULIM01RR000827 · NCRR · UNIVERSITY OF CALIFORNIA, SAN DIEGO · fiscal years 2007 · $3,876 awarded in 2007Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 01:48 UTC. The ranking covers the 200 most relevant of 42 PubMed records, and a shared surname and initials can bring in a namesake. All 42 on PubMed
- 298 citationsRCR 8.3
- Increased dopamine D2/D3 receptor binding after recovery from anorexia nervosa measured by positron emission tomography and [11c]raclopride.Biol Psychiatry · 2005252 citationsRCR 7.0
- 194 citationsRCR 5.9
- Randomized phase II comparison of standard CHOP with weekly CHOP in elderly patients with non-Hodgkin's lymphoma.J Clin Oncol · 1995123 citationsRCR 3.8
- The effects of the alpha-glucosidase inhibitor BAY g 5421 (Acarbose) on meal-stimulated elevations of circulating glucose, insulin, and triglyceride levels in man.Res Exp Med (Berl) · 1979110 citationsRCR 3.8
- Co-trimoxazole prophylaxis during high-dose chemotherapy of small-cell lung cancer.J Clin Oncol · 1985107 citationsRCR 4.1
- Fatty acid consumption and risk of fracture in the Women's Health Initiative.Am J Clin Nutr · 201089 citationsRCR 2.9
- Conjugated equine estrogens and colorectal cancer incidence and survival: the Women's Health Initiative randomized clinical trial.Cancer Epidemiol Biomarkers Prev · 200874 citationsRCR 1.9
- The effects of the alpha-glucosidase inhibitor BAY g 5421 (Acarbose) on postprandial blood glucose, serum insulin, and triglyceride levels: dose-time-response relationships in man.Res Exp Med (Berl) · 197971 citationsRCR 2.6
- A double-blind, placebo-controlled study of risperidone for the treatment of adolescents and young adults with anorexia nervosa: a pilot study.J Am Acad Child Adolesc Psychiatry · 201168 citationsRCR 2.9